WNT5B and hepatocellular carcinoma: We have a hypothesis that Wnt5B, who shows the greatest similarity with Wnt5A, may share a common Fzd receptor2 [40] and mediates similar Wnt5A effects of antagonizing Wnt signaling which may further inhibite HCC proliferation and migration [21, 37].